LOC374443 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.766020E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.576200E-01
Normal-vs-Stage2
3.406300E-02
Normal-vs-Stage3
2.736600E-01
Normal-vs-Stage4
3.072400E-01
Stage1-vs-Stage2
4.368600E-01
Stage1-vs-Stage3
8.050600E-01
Stage1-vs-Stage4
4.565600E-01
Stage2-vs-Stage3
6.164600E-01
Stage2-vs-Stage4
8.223200E-01
Stage3-vs-Stage4
6.263400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.700400E-02
Normal-vs-AfricanAmerican
2.685000E-01
Normal-vs-Asian
2.652600E-01
Caucasian-vs-AfricanAmerican
2.301000E-01
Caucasian-vs-Asian
1.762000E-01
AfricanAmerican-vs-Asian
9.564600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.008200E-01
Normal-vs-Female
7.342300E-02
Male-vs-Female
3.367200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.428600E-01
Normal-vs-Age(41-60Yrs)
2.151800E-01
Normal-vs-Age(61-80Yrs)
2.772600E-01
Normal-vs-Age(81-100Yrs)
3.438800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.943000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.507600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.779000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.217700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.840600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.088200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.273200E-01
Normal-vs-Daily Drinker
2.711800E-01
Normal-vs-Weekly Drinker
2.509400E-01
Normal-vs-Occasional Drinker
1.775750E-01
Normal-vs-Social Drinker
5.082400E-01
Non Drinker-vs-Daily Drinker
2.267600E-01
Non Drinker-vs-Weekly Drinker
8.822100E-02
Non Drinker-vs-Occasional Drinker
5.071600E-01
Non Drinker-vs-Social Drinker
5.406800E-01
Daily Drinker-vs-Weekly Drinker
4.821400E-01
Daily Drinker-vs-Occasional Drinker
1.854760E-01
Daily Drinker-vs-Social Drinker
3.328600E-01
Weekly Drinker-vs-Occasional Drinker
1.080950E-01
Weekly Drinker-vs-Social Drinker
2.636800E-01
Occasional Drinker-vs-Social Drinker
7.851400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.650000E-01
Normal-vs-Grade 2
3.868200E-01
Normal-vs-Grade 3
4.881000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.347600E-01
Grade 1-vs-Grade 3
4.855800E-02
Grade 1-vs-Grade 4
7.650000E-01
Grade 2-vs-Grade 3
1.830760E-01
Grade 2-vs-Grade 4
3.868200E-01
Grade 3-vs-Grade 4
4.881000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.209200E-01
Normal-vs-NonDiabetic
3.385500E-02
Diabetic-vs-NonDiabetic
7.594000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.920200E-01
Normal-vs-NoPancreatitis
3.035600E-01
Pancreatitis-vs-NoPancreatitis
4.630400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.251980E-01
Normal-vs-N1
3.176800E-01
N0-vs-N1
9.093000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.578760E-01
Normal-vs-TP53-NonMutant
3.362200E-01
TP53-Mutant-vs-TP53-NonMutant
1.850160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
